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Leukocyte-Connective Tissue Cell Interaction. I. Stimulation of 
Hyaluronate Synthesis by Live and Dead Leukocytes 
By MICHAEL YARON, M.D., AND C. WILLIAM CASTOR, M.D. 
During the interaction of fibroblasts and 
leukocytes in vitro, there was a two- to 
sixfold increase in the total amount of 
hyaluronate formed, and a corresponding 
increase in the rate (pg./cell/day) of 
hyaluronate synthesis. Increased glucose 
uptake from the culture medium (two- to 
fourfold) was associated with stimula- 
tion of hyaluronate formation. Cultures 
receiving leukocytes suffered an 8 to 33 
per cent decrement in the fibroblast 
population. Leukocytes themselves con- 
WFWRODUCTION of joint fluid hyaluronic 0 acid by rheumatoid synovial tissue 
can be visualized as a consequence of 
altered synthetic activity of specialized 
connective tissue cells functioning in an ab- 
normal milieu of infiltrating lymphoid cells 
and polymorphonuclear leukocytes ( PMN) . 
To explore the nature of possible inter- 
actions between such diverse cell types, we 
established monolayer cultures of human 
fibroblasts from normal and rheumatoid 
articular tissue and incubated these cul- 
tures with isolated leukocytes. The periph- 
eral blood leukocytes were isolated from 
normal persons and rheumatoid patients, 
and the lymphocyte-rich fractions and 
PMN-rich fractions which were prepared 
were added to monolayer fibroblast CUE 
tures to simulate the cell mixtures found in 
the inflamed synovial membrane. 
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sumed little glucose and produced no 
detectable hyaluronate. Viable and non- 
viable lymphocytes and PMN's induced 
qualitatively similar behavioral altera- 
tions in synovial fibroblasts. Fibroblasts 
from normal and rheumatoid joints re- 
sponded similarly to WBC. Normal and 
rheumatoid WBC had similar potential 
for altering the behavior of fibroblasts in 
vitro. Erythrocytes had little effect on 
fibroblast cultures. 
Specific cellular interactions have been 
considered important in directing the se- 
quences of embryonic development, and 
the functional performance of corneal epi- 
thelium and the cells in the underlying 
stroma are known to be interdependent.l 
The possibility that abnormal connective 
tissue cell function might be induced by 
inflammatory cells draws some support 
from studies demonstrating damage to fi- 
broblast cultures caused by addition of 
nonimmune lymphoid cells2 Both phyto- 
hemagglutinin and streptolysin accelerated 
the capacity of lymphoid cells to cause 
plaques (i.e., a visible lesion in the fibro- 
blast monolayer associated with cell de- 
struction), and irradiation, cortisone, and 
chloroquine did not suppress plaque for- 
mation in these mixed cultures. One study 
indicated that lymphoid cells from patients 
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with connective tissue diseases were more 
cytotoxic than those from normal per~ons.~ 
MATERIALS AND METHODS 
Fibroblast cultures were derived from synovial 
tissue obtained at  arthrotomy or amputation and 
were grown as monolayers in serum dilution bot- 
tles as previously reported.4-6 Cells were nourished 
by a semisynthetic medium consisting of 80 per 
cent medium 1066, 10 per cent fetal calf serum, 
and 10 per cent pooled, heat inactivated human 
serum supplemented with L-glutamine. Penicillin 
and streptomycin sulfate (100 pg./ml.) were add- 
ed to the culture medium. 
Separation of lymphocytes from peripheral 
blood was accomplished by the procedure of 
Coulson and Chalmers.7 Freshly drawn blood was 
defibrinated with glass beads" in an Erlenmeyer 
flask by rotating and shaking for 5 min. Defi- 
brinated blood was added to a siliconized prescrip- 
tion bottle, and one part of a 3 per cent solution of 
gelatin) in 0.15 M NaCl was added to three parts 
of blood. The gelatin solution was sterilized with 
a Seitz filter and used fresh at a temperature of 
37OC. The gelatin-blood mixture was incubated 
for 30 min. at 37OC, and the supernatant portion 
was removed. The supernatant fluid was centi- 
fuged at 200 X g for 10 min. to sediment the 
lymphocytes, which were recovered with a yield 
ranging from 15-50 per cent of those in the whole 
blood. Lymphocytes accounted for 70-98 per cent 
of the separated leukocytes. Erythrocytes were 
always present in varying concentrations. These 
lymphocytes appeared viable in that they excluded 
0.4 per cent erythrosine B.8 When phytohemagglu- 
tinin was added to such lymphocyte preparations, 
the transformation rate was 70-90 per cent and 
1-7 per cent of the cells were in mitosis. Evidence 
of transformation was sought after 3 days' incuba- 
tion and 4-6 hours after the addition of colchicine. 
Polymorphonuclear leukocytes were separated 
from peripheral blood using a modification of the 
method described by Rabin0witz.B Fresh blood 
was drawn in a plastic syringe containing 500 
units of preservative-free heparin for each milli- 
liter of blood. The heparinized blood was sedi- 
mented in the syringe for 1 hour at 37OC and the 
supematant suspension of leukocytes in plasma 
was transferred to a prescription bottle, using a 
bent needle to avoid inverting the syringe. Pre- 
scription bottles were previously washed with 
"Clear glass beads, 5 mm. in diameter, from 
)Baker and Adamson, code number 1797. 
Matheson Company. 
concentrated nitric acid, exhaustively rinsed with 
double distilled water, and siliconized. Medium 
consisting of 80 per cent medium 1066 and 20 
per cent human serum, supplemented with L-glut- 
amine, penicillin, and streptomycin in a volume 
equal to X that of the plasma, was added to the 
prescription bottle and the mixture incubated at 
37OC for 30 min. After incubation the supernatant 
fluid was discarded, leaving a visible layer of cells 
attached to the floor of the flask. A solution 
of buffered saline with EDTA was added imme- 
diately, and the prescription flask was gently 
shaken for 10 min. at room temperature while the 
clear saline solution became increasingly cloudy 
as cells detached from the glass. To wash the leu- 
kocytes from 60.0 ml. of blood, 40 ml. of the 
buffered saline with EDTA was used.* The cell 
suspension was centrifuged at 200 X g for 10 min. 
at room temperature. Staining with erythrosine B 
showed 100 per cent viability (e.g., dye exclusion). 
Polymorphonuclear leukocytes obtained by this 
method exhibited active ameboid motion when 
planted on fibroblasts in tissue culture flasks, and 
Wright stains showed preservation of cellular struc- 
ture and cytoplasmic granulation. The yield ranged 
between 20 and 30 per cent of the initial number 
of PMN cells in the blood drawn and a purity of 
70-95 per cent, the contaminants being primarily 
mononuclear cells with a few erythrocytes. 
Phytohemagglutinin (PHA) used in the inter- 
action experiments was phytohemagglutinin-P,t 
and 0.02 ml. of phytohemagglutinin (from the 5 
ml. in the original container) was added to each 
10 ml. of medium. The dry PHA was diluted with 
hemagglutinination buffer.) 
Replicate cultures of fibroblasts were planted in 
either T-30 flasks or serum dilution bottles. The 
inoculum in different experiments ranged from 0.4 
to 1.0 X 106, and each experimental group in the 
protocol contained three flasks. Towards the end 
of the fibroblast growth cycle, 5.0 X 106 washed 
leukocytes were added to the fibroblast cultures 
along with complete medium replacement. Except 
where specifically noted, lymphocytes were incu- 
bated for 3 days with fibroblast monolayers and 
polymorphonuclear leukocytes for 2 days. At the 
end of the 7 day growth cycle, the cultures were 
separated from the glass with trypsin and the re- 
sulting cell suspension enumerated and sized using 
a Coulter model B cell counter with the lower 
"Buffered saline with EDTA was made as fol- 
lows: disodium EDTA, 0.2 Gm.; NaCI, 8.0 Gm.; 
KCI, 0.2 Gm.; N%HPO,, 1.15 Gm.; KH,PO,, 0.2 
Gm.; glucose, 0.2 Gm.; and water, 1000 ml. 
)Difco Laboratories, Detroit, Mich. 
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Table 1.-Effects of Viable Polymorphonudear Leukocytes on “Rheumatoid” Fibroblasts 
Final fibroblast Glucose uptake, Total HA synthesis 
mg./lOB HA/flask. rate, 
cells/day P8. pg./cell/day 
Fibroblast Leukocyte+ COUnt MCV,t 
strain* Diagnosis additive x 100 P 
P.G.-D,1 RA None 1.533 2400 0.42 40.0 13.0 
P.G.-D,2 RA None 1.841 2530 0.32 51.6 14.0 
P.G.-D,3 RA None 1.888 2450 0.30 48.0 12.7 
Average - - 1.754 2493 0.34 46.5 13.2 
P.G.-D,4 RA PMN,, 1.473 3100 1.49 283.0 96.1 
P.G.-D,5 RA PMN,, 1.675 2980 1.31 189.0 56.4 
P.G.-D,6 RA PMN,, 1.417 2990 1.55 245.0 86.5 
- - - - - 
- - - - -
Average - - 1.522 3023 1.45 239.0 79.7 
P.G.-D,7 RA PMN, 1.250 2890 1.76 267.0 106.8 
P.G.-D,8 RA PMN, 1.722 2890 1.28 270.0 78.4 
P.G.-D,S RA PMN, 1.733 2890 1.15 260.0 75.0 
Average - - 1.565 2890 1.40 266.0 86.7 - - - - - 
Fibroblast inoculum = 0.4 X 106/flask. 
P.G. refers to the initials of the donor, while the D indicates the number of times (4 )  the strain 
has been subcultured. Individual flasks were numbered serially. 
t Polymorphonuclear leukocyte inocula, both normal (PMN,) and rheumatoid (PMN,,), were 5.0 
x 106 cells/flask. Purity of the PMN preparation was 95%. The “interaction” period for the two kinds 
of cells together was the last 2 days of a 7 day growth cycle. 
$ MCV = mean cell volume. 
threshold set to exclude blood cells and debris. 
Viability of the fibroblast suspension was esti- 
mated by the erythrosine B exclusion method.8 
The residual glucose in culture media was mea- 
sured using a glucose oxidase method.10 Hyalu- 
ronic acid in culture media was measured by a 
method published earlier from this laboratory 
wherein the mucopolysaccharide is isolated and 
its uronic acid content determined.11 The detailed 
format of individual experiments can be best ap- 
preciated from the tables. 
Glucose uptake was calculated from the fol- 
lowing relation: - 
c, - c, mg. glucose/lOe cells/day= T X cell count 
where C, = mg. glucose in unused medium, C, = 
residual glucose in medium from the final medium 
change in the culture cycle, T =  time in days 
that last medium change was in contact with the 
culture, and the cell count is expressed in units 
of 1 million. The hyaluronic acid synthesis rate 
is also calculated from the hyaluronic acid mea- 
surement in the last medium change and the total 
fibroblast count, using this relation: - 
fig. HA 
T X cell count 
pg. HA/cell/day = 
where T = time in days during which final me- 
dium change was in contact with the cells, and 
the cell count refers to the total number present 
in the flask. As an example, the data concerning 
culture PGD,, flask 1 (Table 1 ), were calculated 
as follows: 
40 Pg. 
2 days X 1.533 X 100 HA synthesis rate = 
= 13.0 pg./cell/day 
RESULTS 
Synovial fibroblasts from an elbow of a 
patient (P.G. ) with rheumatoid arthritis 
produced 6.0 times more hyaluronic acid 
per cell per day than control cultures when 
interacted with allogeneic PMNRA, and 6.6 
times more when interacted with allogeneic 
PMNN (Table 1). There was a correspond- 
ing increase in glucose consumption when 
compared to controls. Polymorphonuclear 
leukocytes from both sources induced a 
minor decrease in the mean total cell count. 
When the same strain of fibroblasts was 
incubated with lymphocytes in a separate 
experiment (Table 2), the increase in 
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Table 2.Effects of Viable Lymphocytes* on “Rheumatoid” Fibroblastsf 
Fibroblast Leukocyte 




P.G.-D RA None 
P.G.-D RA L R A  
P.G.-D RA LN 
P.G.-D RA PHAt 
P.G.-D RA LEA* PHA 


























































* Lymphocytes from normal persons ( LN) and rheumatoid patients ( LRA) were added in a concen- 
tration of 5.0 x 106 cells, 80% purity. The fibroblast inoculum was 0.6 x 106 cells/flask. The “inter- 
action” time was the final 3 days of a 7 day growth cycle. 
f The numbers presented include the mean values of observations (or derived numbers), and the 
figures in parentheses are the absolute range of the triplicate observations, or derived numbers. 
$ Phytohemagglutinin-P was used in a concentration of 0.02 ml. per 10 ml. of complete culture 
medium. 
Table 3.Effects of Viable Polymorphonuclear Leukocytes on ‘‘Normal’’ Fibroblasts 
Final fibroblast Glucose uptake, Total HA synthesis 
stram Diagnosis additive x 10’ P3 cells/day Pg. pg. lceUhy 
Fibroblast Leukocyte count MCV. mg./lOB HA/flask, rate 
D.M.-I Normal None 2.44 2800 0.96 309.4 64.9 
D.M.-I Normal PMNRA 2.28 3680 1.06 362.6 77.8 
D.M.4 Normal PMNa 2.21 3610 1.07 331.2 74.8 
(2.36-2.64) (2800-2800) (0.89-1.01) (302.0-316.8) (62.4-67.5) 
(2.18-2.38) (2560-3800) (1.00-1.09) (360.4-367.6) (73.6-82.0) 
(2.16-2.28) (3650-3680) ( 1.03-1.10 ) (327.4-338.4) (74.2-76.9) 
Fibroblast inoculum was 0.4 x 106/flask, PMN,, inoculum was 4.6 x 106 cells/flask (70% purity), 
and PMN, inoculum was 5.0 x 106 cells/flask (80% purity). The “interaction” time was 2 days. 
hyaluronate production per cell per day 
was over four times the control value. There 
was a marked increase in glucose uptake in 
both groups, similar to that noticed in the 
PMN experiment. A modest decrease in the 
final number of lymphocyte-treated fibro- 
blasts was noted, also similar in magnitude 
to that seen with PMN leukocytes. The via- 
bility of the fibroblasts was not significantly 
affected by interaction with blood cells, 
since over 90 per cent excluded erythro- 
sine B. 
“Normal” synovial fibroblasts obtained 
from the wrist of a young woman (D.M.) 
who had had surgery for a congenital mal- 
formation were interacted with allogeneic 
PMNRA and PMNN. In this experiment 
(Table 3), only modest stimulation of the 
specific rate of hyaluronate synthesis was 
noted. A similar increase was noted on a 
second occasion (Table 4) .  On the other 
hand, when the same strain of fibroblasts 
was incubated with different allogeneic 
PMNR, on another occasion (Table 5 ) ,  
they produced four times more hyaluronate 
per cell per day than the controls. It is of 
interest that on both occasions when the 
increase in hyaluronate production by the 
interacted cells was minimal, the “basal” 
rate of hyaluronate production of control 
cultures was high (compared with the con- 
trol in Table 5 ) .  In most experiments, an 
increase of the mean corpuscular volume of 
the interacted fibroblasts was recorded. 
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Table 4.4omparison of the Effects of Viable and Nonviable Polymorphonuclear 
Leukocytes on Normal Fibroblasts 
Final fibroblast Glumse uptake, Total HA synthesis 
strain Diaenosis additive x 100 N3 cells/day fig. pg./cell/day 
Fibroblast Leukocyte count MCV, mg./lW HA/flask, rate, 
I ~~ 
D.M.-G Normal None 4.47 2316 0.36 354.0 39.6 
D.M.-G Normal Viable PMNN 3.17 3150 0.60 296.6 46.8 
D.M.-G Normal Nonviable PMNN 4.21 2296 0.41 386.6 45.9 
(4.36-4.64) (2250-2350) (0.35-0.37) (334.0-392.0) (36.0-44.5) 
(3.00-3.28) (3150-3150) (0.58-0.63) (288.&302.0) (43.9-50.0) 
(4.12-4.34) (2290-2300) (0.41-0.42) (360.0-424.0) (43.7-48.8) 
Fibroblast inoculum was 0.86 x 106/flask; PMN, inoculum was 5.0 X 106, 78% purity. The “inter- 
action” time was the final 2 days of a 7 day growth cycle. 
Table 5.4omparison of Effects of Viable and Nonviable Leukocyte Mixtures 
on Normal Fibroblasts 
Final fibroblast Glucose uptake, 
Fibroblast Leukocyte count MCV, m /I08 







D.M.-F Normal None 4.31 
D.M.-F Normal Viable leukna 3.16 
D.M.-F Normal Nonviable 1eUknA 3.38 





























The preparation leuk,, contained 50% lymphocytes; the remainder were mostly PMN. The inocu- 
lum of leuk,, was 10.0 x 106. The inoculum of viable PMN,, was 4.6 x 106 cells/flask (90%); the 
fibroblast inoculum was 0.65 x 106/flask. The “interaction” time was the final 3 days of a 7 day growth 
cycle. 
Table 6 .Effects  of Viable Lymphocytes on Normal Fibroblasts 
Final fibroblast Glucose uptake, Total HA synthesis 
Fibroblast Leukocyte count MCV, mg./lW HA/&&. rate, 
D.M.-G Normal None 3.793 2307 0.15 328.3 29.3 
strain Diagnosis additive x 10” P3 cells/day pg. pg./cell/day 
(3.260-4.200) (2300-2320) (0.15-0.16) (301.0-340.0) (23.9-34.3) 
(2.260-2.960) (2430-2520) (0.49-0.65) (656.0-750.4) (73.9-110.7) 
(2.980-8.660) (2400-2460) (0.41-0.49) (832.0-912.0) (80.6-93.1) 
D.M.-G Normal LEA 2.527 2467 0.59 703.3 94.7 
D.M.-G Normal LN 3.360 2427 0.44 866.6 86.4 
The fibroblast inoculum was 0.4 x 108, L,, inoculum was 4.6 x 106 cells/flask (70% purity), and 
the L, inoculum was 5.0 x 106 cells/flask (80% purity). The “interaction” interval was the final 2 
days of a 7 day culture cycle. 
When normal fibroblasts (D.M. ) were 
incubated with allogeneic L,A and LN 
( Table 6 ) , hyaluronate production in- 
creased about threefold. A minor increase 
in the mean cell volume was seen. Glucose 
uptake per flask was three to four times 
control values for L, and L,, stimulated 
cultures. 
Mixtures of viable WBC incubated with 
“normal” fibroblasts (D.M.) (Tables 5 and 
7)  showed a large increase in hyaluronate 
formation. Erythrocytes, even when added 
in very large numbers, had virtually no ef- 
fect on the parameters measured (Table 7) .  
The Etect of Frozen-Thawed Leukocytes 
To determine whether viability of leuko- 
cytes was required to induce altered con- 
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Table 7.4omparison of the Effects of Viable Leukocytes and Erythrocytes on 
Normal Fibroblasts 
Final fibroblast Glucose uptake, 
Fibroblast Leukocyte count MCV, :&$A 
strain Diagnosis additive x 1w P 
D.M.-G Normal None 6.06 
D.M.-G Normal PMNN 3.87 
D.M.-G Normal leukx 4.07 











































The fibroblast inoculum was 1.0 x 106/flask; PMN, inoculum was 5.0 x 106 (95% purity); leuk, 
inoculum was 5.0 x 106 (45% lymphocytes); erythrocyte (erythro,) inoculum was 35.0 x 106/flask. 
The “interaction” time was the hal 3 days of a 7 day growth cycle. 
nective tissue cell behavior, we subjected 
equivalent numbers of leukocytes to three 
cycles of freeze-thawing and added the cell 
debris to fibroblast cultures, with the re- 
sults summarized in Tables 4, 5, 7, and 8. 
These data indicate that dead lymphocytes 
and, to a lesser degree, dead polymorpho- 
nuclear leukocytes, both separately and to- 
gether, alter fibroblast function in the same 
directions and nearly to the same degree as 
their live counterparts. Where glucose up- 
take by 5.0 X lo6 viable leukocytes was 
measured in the absence of fibroblasts, con- 
sumption was only about 1/5 that seen in 
control fibroblast cultures. These data sug- 
gest that the added leukocytes themselves 
play little part in the increased glucose 
consumption, but that they accelerate fibro- 
blast utilization of glucose concurrent with 
the outpouring of fibroblast-formed hyalu- 
ronate. 
The Effect of Lymphocyte “Activation” on 
In the presence of PHA (Table 2),  lym- 
phocytes were adherent to the fibroblastic 
monolayer after about 1% hours, and after 
3 days approximately 50 per cent of them 
were still attached to the fibroblasts while 
the remainder floated in clumps. In the ab- 
sence of PHA, most of the lymphocytes 
Boated or were loosely attached to the fi- 
broblast monolayer. The presence of PHA 
“Interaction” Phenomena 
alone caused a 25 per cent decrease in the 
final cell count as compared to the controls, 
while the addition of rheumatoid lympho- 
cytes and normal lymphocytes in the pres- 
ence of PHA caused a 55 and 40 per cent 
decrease, respectively. All the additives in 
this experiment caused a similar increase in 
the mean corpuscular volume of “inter- 
acted‘‘ fibroblasts. The glucose uptake was 
only slightly increased by PHA alone, while 
it was significantly increased by the addi- 
tion of lymphocytes alone or by both lym- 
phocytes and PHA. There was a minimal 
increase in the formation of hyaluronic acid 
when only PHA was present in the medium, 
while there was a large increase in the pro- 
duction of hyaluronic acid when the addi- 
tive included lymphocytes. 
Zdentification of Culture-Produced 
Hyaluronate 
By virtue of the analytic procedure for 
measuring culture-produced acid mucopoly- 
saccharides, it was clear that synovial fi- 
broblasts added a cetylpyridinium chloride- 
precipitable macromolecule containing 
uronic acid to the culture medium.ll While 
this has been adequately characterized as 
hyaluronic acid in media from typical syno- 
vial cultures: it seemed prudent to char- 
acterize the acid mucopolysaccharide 
(MPS) from leukocyte-treated cultures. Vis- 
cometric measurements controlled with 
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Table 8.-Effects of Viable and Nonviable Lymphocytes on Normal Fibroblasts 
Final fibroblast Glumse uptake, Total HA synthesis 
Fibroblast Leukocyte munt MCV, mg./lW HA/flask, rate, 
strain Diagnosis additive x 108 cells/dau pg. pg./Ceu/day 
Wa.K.-I Normal None 6.10 1800 0.16 160 13.2 
Wa.K.-I Normal Viable LN 4.89 1567 0.65 506.7 52.4 
Wa.K.-I Normal Nonviable LN 5.12 1800 0.48 439.3 41.9 
(5.66-6.47) (1800-1800) (0.15-0.19) (152-168) (12.3-14.9) 
(4.56-5.62) (1500-1600) (0.56-0.10) (488-544) (44.2-59.6) 
(4.76-5.45) (1700-1900) (0.44-0.60) (552.M92.0) (37.0-45.3) 
The fibroblast inoculum was 1.06 x W/flask; L, inoculum was 5.0 x 106/flask (80% purity). The 
“interaction” time was the final 2 days of a 7 day culture cycle. 
Table 9.4haracterization of Isolated Culture-Produced Hyaluronate (HA) 
Measurement on Control cultures Cultures 
Hexosamine Glucosamine Glucosamine Glucosamine 12 
isolated HA cultures + LEA + PMNEA Method, ref. no. 
Hexosamine: hexuronic acid ratio 0.73 0.84 0.82 18, 14 
Carbazole: orcinol ratio 1.09 1.18 0.90 15.16 
CSC of CPC Complex* 0.1 M MgCI, 0.1 M M&I, 0.1 M MgCI, 17 
Protein, % 5.7 4.4 7.4 18 
* CSC refers to the initial salt concentration required to prevent flocculation of a mucopolysaccha- 
ride-cetylpyridinium complex in aqueous solution. 
testicular hyaluronidasee made it clear that 
the culture-produced mucopolysaccharide 
was hyaluronidase-labile and of high mole- 
cular weight ( [ q ]  = 15-18). Medium sam- 
ples from control, PMN, and lymphocyte- 
treated cultures were subjected to proteo- 
lytic digestion (pronase); the mucopoly- 
saccharide was then isolated with cetylpyri- 
dinium chloride and converted to the so- 
dium salt. As shown in Table 9, the muco- 
polysaccharide preparations were essen- 
tially protein-free and exhibited a critical 
salt concentration for the cetylpyridinium 
chloride-MPS complex typical of hyaluro- 
nate.17 In addition, the carbazo1e:orcinol 
ratio was typical of hyaluronate (approxi- 
mately 1.0). Hydrolysis of aliquots of iso- 
lated MPS permitted measurement and 
identification of the hexosamine moiety, 
which was entirely glucosamine. In sum- 
mary, the leukocyte-treated cultures made 
the same MPS (hyaluronate) which is char- 
acteristic of control synovial cultures; thus, 
the leukocyte-induced alteration in muco- 
polysaccharide metabolism appears to be 
entirely quantitative in this model system. 
DISCUSSION 
These experiments demonstrated that 
both viable and disrupted leukocytes in- 
duced overproduction of hyaluronic acid by 
fibroblasts when the two types of cells were 
associated in vitro. Both lymphocytes and 
polymorphonuclear leukocytes had this 
stimulatory effect on connective tissue cells, 
and neither produced measureable hyalu- 
ronic acid when cultured alone. 
Recent evidence indicates that human 
leukocytes contain and may synthesize 
small amounts of acid mucopolysaccharide 
thought to be chondroitin sulfate.lS Since 
these authors needed 100 times as many 
leukocytes as we used, in addition to sensi- 
tive tracer methods, it is not surprising that 
our chemical analyses of leukocytes in the 
numbers used in our experiments disclosed 
no significant mucopolysaccharide uronic 
acid contribution from that source. 
Analysis of the increased mucopolysac- 
charide formed under the leukocyte in- 
fluence showed it to be hyaluronic acid, 
the product normally formed by fibroblasts 
of synovial origin. It appeared to make little 
372 MICHAEL YARON AND C, WILLIAM CASTOR 
difference whether the leukocytes came 
from normal persons or patients with rheu- 
matoid arthritis. In the same manner, both 
“normal” and “rheumatoid fibroblasts were 
capable of responding to the leukocyte in- 
fluence. 
Accelerated glucose disappearance also 
occurred during the cellular interaction, and 
the magnitude of the increment in glucose 
uptake seemed to paralIel the increased 
hyaluronate formation. Accelerated glucose 
disappearance was always accompanied by 
a rapid decrease in medium pH. Since leu- 
kocytes alone removed little medium glu- 
cose, and since disrupted leukocytes also 
caused increased glucose disappearance, it 
is reasonable to conclude that the leuko- 
cytes caused the fibroblasts to remove in- 
creased amounts of glucose from the 
medium. 
Under the conditions of these experi- 
ments, leukocytes usually induced a modest 
reduction in the fibroblast population. Other 
investigators, using microscopic methods, 
have described a toxic effect of lympho- 
cytes on fibroblasts in tissue culture.2.3 The 
present experiments provide quantitative 
support for such observations and suggest 
that this “toxic’ effect may be nonspecific, 
perhaps related to profound depletion of 
medium glucose or to hydrogen ion excess. 
Phytohemagghitinin caused tight adher- 
ence of the lymphocytes to the fibroblastic 
monolayer and increased toxicity to the 
fibroblasts. Lymphocytes have previously 
been shown to be toxic to fibroblasts and 
other target cells in the presence of phy- 
tohemagglutinin.20.21 In the present experi- 
ments, this toxicity, measured by fibroblast 
counts, was more profound when rheuma- 
toid lymphocytes were the “attacking” cells. 
Whether this would be generally true for 
rheumatoid lymphocytes is unknown. Since 
Nowell’s initial reportzz showing the ability 
of phytohemagglutinin to induce ‘8lastoid” 
transformation and mitosis in lymphocytes, 
subsequent reports have shown that the 
phytohemagglutinin may increase the anti- 
body production of the lympho~yte ,~~ and 
one of these reportsz4 suggests that lympho- 
cytes from a patient with acute rheumatoid 
arthritis in the presence of PHA showed 
more stimulation of globulin synthesis than 
lymphocytes from normal persons. The pres- 
ent experiments demonstrated a toxic effect 
of phytohemagglutinin alone on the fibro- 
blastic monolayer, causing decrease in the 
fibroblast count, the phytohemagglutinin 
alone being more toxic in this respect than 
lymphocytes alone. Interaction experiments 
carried out in the presence of phytohemag- 
glutinin must be considered in the light 
of demonstrated effects of the mitogenic 
agent alone on the target fibroblasts. Since 
the PHA effects were capricious, varying 
with the concentration, age, and particular 
batch of PHA, we found experiments which 
included this agent difficult to interpret, 
and for this reason chose to emphasize the 
results of experiments where leukocytes and 
connective tissue cells were interacted in 
the absence of this complicating additive. 
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SUMMAFUO IN INTERLINGUA 
Durante le interaction de fibroblastos e leucocytos observate in vitro, un duple a 
sextuple augmento esseva notate in le quantitate total del hyaluronato formate insimul 
con un correspondente augmento in le prorata (pg/cellula/die) del synthese de hy- 
aluronato. Le augmentate acceptation de glucosa ab le medio cultural (per un factor 
de 2 a 4) esseva associate con stimulation del formation de hyaluronato. Culturas 
recipiente leucocytos suffreva un declino per 8 a 33 pro cento in le population de 
fibroblastos. Le leucocytos como tal consumeva pauc glucosa e produceva nulle detegi- 
bile hyaluronato. Viabile e nonviabile lymphocytos e neutrophilos polymorphonucleari 
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induceva qualitativemente simile alterationes del comportamento de fibroblastos 
synovial. Fibroblastos a b  articulationes normal e rheumatoide respondeva similemente 
a leucocytos. Leucocytos normal e rheumatoide habeva simile potentiales pro alterar le 
comportamento de fibroblastos in vitro. Erythrocytos exerceva pauc effect0 super 
culturas de fibroblastos. 
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